Literature

1) Nejabati HR, Mihanfar A, Pezeshkian M, Fattahi A, Latifi Z, Safaie N, Valiloo M, Jodati AR, Nouri M. N1-methylnicotinamide (MNAM) as a guardian of cardiovascular system. J Cell Physiol. 2018, 1–9.

2) Ström K, Morales-Alamo D, Ottosson F, Edlund A, Hjort L, Jörgensen SW, Almgren P, Zhou Y, Martin-Rincon M, Ekman C, Pérez-López A, Ekström O, Perez-Suarez I, Mattiasson M, de Pablos-Velasco P, Oskolkov N, Ahlqvist E, Wierup N, Eliasson L, Vaag A, Groop L, Stenkula KG, Fernandez C, Calbet JAL, Holmberg HC, Hansson O. N1-methylnicotinamide is a signalling molecule produced in skeletal muscle coordinating energy metabolism. Sci Rep. 2018, 8: 3016.

3) Taniki N, Nakamoto N, Chu PS, Mikami Y, Amiya T, Teratani T, Suzuki T, Tsukimi T, Fukuda S, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ebinuma H, Kanai T. Intestinal barrier regulates immune responses in the liver via IL-10–producing macrophages. JCI Insight. 2018, 3: e91980.

4) Pissios P. Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme. Trends Endocrinol Metab. 2017, 28(5): 340-353.

5) Turk D et all., EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), Scientific Opinion, Safety of 1-methylnicotinamide chloride (1-MNA) as a novel food pursuant to Regulation (EC) No 258/97. EFSA Journal. 2017, 15(10): 5001.

6) Jakubowski A, Sternak M, Jablonski K, Ciszek-Lenda M, Marcinkiewicz J, Chlopicki S. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α. Int Immunopharmacol. 2016, 31: 98-104.

7) Jiang N, Wang M, Song J, Liu Y, Chen H, Mu D, Xia M. N-methylnicotinamide protects against endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice. Mol Nutr Food Res. 2016, 60: 1625-36.

8) Mateuszuk L, Jasztal A, Maslak E, Gasior-Glogowska M, Baranska M, Sitek B, Kostogrys R, Zakrzewska A, Kij A, Walczak M, Chlopicki S. Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice: A Comparison with Nicotinic Acid. J Pharmacol Exp Ther. 2016, 356(2): 514-24.

9) Hong S, Moreno-Navarrete JM, Wei X, Kikukawa Y, Tzameli I, Prasad D, Lee Y, Asara JM, Fernandez-Real JM, Maratos-Flier E, Pissios P. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nat Med. 2015, 21: 887-94.

10) Przyborowski K, Wojewoda M, Sitek B, Zakrzewska A, Kij A, Wandzel K, Zoladz JA, Chlopicki S. Effects of 1-Methylnicotinamide (MNA) on Exercise Capacity and Endothelial Response in Diabetic Mice. PLoS One. 2015, 10(6): e0130908.

11) Tanaka Y, Kume S, Araki H, Nakazawa J, Chin-Kanasaki M, Araki S, Nakagawa F, Koya D, Haneda M, Maegawa H, Uzu T. 1-Methylnicotinamide ameliorates lipotoxicity induced oxidative stress and cell death in kidney proximal tubular cells. Free Radic Biol Med. 2015, 89: 831-41.

12) Milani ZH, Ramsden DB, Parsons RB. Neuroprotective effects of nicotinamide N-methyltransferase and its metabolite 1-methylnicotinamide. J Biochem Mol Toxicol. 2013, 27: 451-6.

13) Schmeisser K, Mansfeld J, Kuhlow D, Weimer S, Priebe S, Heiland I, Birringer M, Groth M, Segref A, Kanfi Y, Price NL, Schmeisser S, Schuster S, Pfeiffer AFH, Guthke R, Platzer M, Hoppe T, Cohen HY, Zarse K, Sinclair DA, Ristow M. Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat Chem Biol. 2013, 9: 693-700.

14) Barbieri SS, Amadio P, Gianellini S, Tarantino E, Zacchi E, Veglia F, Howe LR, Weksler BB, Mussoni L, Tremoli E. Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner. Circulation. 2012, 126: 1373-84.

15) Domagala TB, Szeffler A, Dobrucki LW, Dropinski J, Polanski S, Leszczynska-Wiloch M, Kotula-Horowitz K, Wojciechowski J, Wojnowski L, Szczeklik A, Kalinowski L. Nitric oxide production and endothelium-dependent vasorelaxation ameliorated by N1-methylnicotinamide in human blood vessels. Hypertension. 2012, 59: 825-32.

16) Parsons RB, Aravindan S, Kadampeswaran A, Evans EA, Sandhu KK, Levy ER, Thomas MG, Austen BM, Ramsden DB. The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors. Biochem J. 2011, 436: 145-55.

17) Watala C, Kazmierczak P, Dobaczewski M, Przygodzki T, Bartus M, Lomnicka M, Slominska EM, Durackova Z, Chlopicki S. Anti-diabetic effects of 1-methylnicotinamide (MNA) In streptozocin-induced diabetes in rats. Pharmacol Rep. 2009, 61: 86-98.

18) Bartus M, Lomnicka M, Kostogrys RB, Kazmierczak P, Watala C, Slominska EM, Smolenski RT, Pisulewski PM, Adamus J, Gebicki J, Chlopicki S. 1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats. Pharmacol Rep. 2008, 60: 127-38.

19) Biedron R, Ciszek M, Tokarczyk M, Bobek M, Kurnyta M, Slominska EM, Smolenski RT, Marcinkiewicz J. 1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages. Arch Immunol Ther Exp (Warsz). 2008, 56: 127-34.

20) Bryniarski K, Biedron R, Jakubowski A, Chlopicki S, Marcinkiewicz J. Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin. Eur J Pharmacol. 2008, 578: 332-8.

21) Chlopicki S, Swies J, Mogielnicki A, Buczko W, Bartus M, Lomnicka M, Adamus J, Gebicki J. 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br J Pharmacol. 2007, 152: 230-39.

22) Menon RM, Gonzalez MA, Adams MH, Tolbert DS, Leu JH, Cefali EA. Effect of the rate of Niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites. J Clin Pharm Online. 2007, 47(6): 681-88.

23) Menon RM, Adams MH, Gonzalez MA, Tolbert DS, Leu JH, Cefali EA. Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation. Int J Clin Pharmacol Ther. 2007, 45: 448-454.

24) Sugihara K, Tayama Y, Shimomiya K, Yoshimoto D, Ohta S, Kitamura S. Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridones, and intraspecies variation of the enzyme activity in rats. Drug Metab Dispos. 2006, 34(2): 208-12.

25) Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A. Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin Exp Dermatol. 2005, 30: 632-35.

26) Gebicki J, Sysa-Jedrzejowska A, Adamus J, Wozniacka A, Rybak M, Zielonka J. 1-methylnicotinamide: a potent anti-inflammatory agent of vitamin origin. Pol. J. Pharmacol. 2003, 55: 109-112.

27) Choi J, Hammer LW, Hester RL. Calcium-dependent synthesis of prostacyclin in ATP-stimulated venous endothelial cells. Hypertension. 2002, 39: 581-5.

28) Pumpo R, Sarnelli G, Spinella A, Budillon G, Cuomo R. The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production. Am J Gastroenterol. 2001, 96: 1183–1187.

29) Aoyama K, Matsubara K, Okada K, Fukushima S, Shimizu K, Yamaguchi S, Uezono T, Satomi M, Hayase N, Ohta S, Shiono H, Kobayashi S. N-methylation ability for azaheterocyclic amines is higher in Parkinson’s disease: nicotinamide loading test. J Neural Transm. 2000, 107: 985–995.

30) Erb C, Seidel A, Frank H, Platt KL, Oesch F, Klein J. Formation of N-Methylnicotinamide in the brain from a dihydropyridine-type prodrug. Biochemical Pharmacol. 1999, 57: 681-684.

31) Taguchi H, Sakaguchi M, Shimabayashi Y. Contents of quinolinic acid trigonelline and N-1 methylnicotinamide in various foods and thermal conversion of these compounds into nicotinic acid and nicotinamide. Vitamins. 1986, 60(11): 537-46.

32) Stanulovic M, Chaykin S. Aldehyde oxidase: catalysis of the oxidation of N 1-methylnicotinamide and pyridoxal. Arch Biochem Biophys. 1971, 145: 27–34.

33) Felsted R, Chaykin S. N-Metylnicotinamide oxidation in a number of mammals. J Biol Chem. 1967, 242: 1274-1279.